Literature DB >> 4180089

Impaired immunity in the etiology of amyloidosis: a speculative review.

T J Muckle.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 4180089

Source DB:  PubMed          Journal:  Isr J Med Sci        ISSN: 0021-2180


× No keyword cloud information.
  10 in total

Review 1.  [Experimental principles of amyloidosis therapy].

Authors:  W Zschiesche
Journal:  Klin Wochenschr       Date:  1969-12-01

2.  Amyloid goitre.

Authors:  P D James
Journal:  J Clin Pathol       Date:  1972-08       Impact factor: 3.411

3.  Transfer amyloidosis. Studies on the nature of the amyloid inducing factor in a murine transfer system.

Authors:  F Hardt; P Hellung-Larsen
Journal:  Clin Exp Immunol       Date:  1972-03       Impact factor: 4.330

4.  Cellular immunity in casein-induced amyloidosis.

Authors:  E S Cathcart; M Mullarkey; A S Cohen
Journal:  Immunology       Date:  1971-06       Impact factor: 7.397

5.  Casein-induced experimental amyloidosis. III. Response to mitogens, allogeneic cells, and graft-versus-host reactions in the murine model.

Authors:  M A Scheinberg; E S Cathcart
Journal:  Immunology       Date:  1974-11       Impact factor: 7.397

6.  Induction of amyloidosis in germ-free NMRI-mice after prolonged stimulation with sterilized casein.

Authors:  M H Claesson; F Hardt
Journal:  Clin Exp Immunol       Date:  1972-06       Impact factor: 4.330

7.  Casein-induced experimental amyloidosis. VI. A pathogenic role for b cells in the murine model.

Authors:  M A Scheinberg; E S Cathcart
Journal:  Immunology       Date:  1976-09       Impact factor: 7.397

8.  Cell-mediated immunity in amyloidosis secondary to lepromatous leprosy.

Authors:  E M Anders; K P McAdam; R F Anders
Journal:  Clin Exp Immunol       Date:  1977-01       Impact factor: 4.330

9.  Immunological responses to Candida albicans II. Amyloidosis in mice induced by candidiasis.

Authors:  N N Pearsall; D Lagunoff
Journal:  Infect Immun       Date:  1974-12       Impact factor: 3.441

10.  Experimental amyloidosis: the inducer is a polyclonal B-cell activator to which susceptibility is under genetic control.

Authors:  S Britton
Journal:  J Exp Med       Date:  1975-12-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.